Ketogenic Diet in Super-Refractory Status Epilepticus

Area of Science:

• Pediatric Neurology
• Neurocritical Care
• Metabolic Therapies

Background:

• Super-Refractory Status Epilepticus (SRSE) presents a significant therapeutic challenge in pediatric populations.
• Existing treatments for SRSE often have limited efficacy and carry substantial risks.
• The Ketogenic Diet (KD) is a well-established therapy for refractory epilepsy, but its use in SRSE is less explored.

Purpose of the Study:

• To evaluate the feasibility of initiating the Ketogenic Diet (KD) in pediatric patients diagnosed with Super-Refractory Status Epilepticus (SRSE).
• To determine the complication rate associated with KD implementation in this vulnerable patient group.
• To assess the effect of the Ketogenic Diet on seizure frequency and control in pediatric SRSE.

Main Methods:

• Retrospective chart review of pediatric patients with SRSE who initiated KD.
• Data collection focused on KD initiation, adherence, adverse events, and seizure outcomes.
• Feasibility assessed by successful implementation and tolerability of the diet.

Main Results:

• The Ketogenic Diet was successfully initiated in pediatric patients with SRSE.
• The rate of complications related to KD initiation was evaluated.
• Preliminary data on the impact of KD on seizure frequency in SRSE patients was analyzed.

Conclusions:

• Initiating the Ketogenic Diet is a feasible therapeutic option for pediatric patients suffering from Super-Refractory Status Epilepticus.
• The study provides insights into the safety profile and potential efficacy of KD in managing this severe neurological condition.
• Further research is warranted to confirm the benefits of KD in improving seizure control for pediatric SRSE.